MicroRNA-125a-3p reduces cell proliferation and migration by targeting Fyn

Journal of Cell Science

Volumn 126, Issue 13, 2013, Pages 2867-2876

  Ninio Many, Lihi ^a   Grossman, Hadas ^a   Shomron, Noam ^a   Chuderland, Dana ^a   Shalgi, Ruth ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Fyn; Migration; MiR 125a 3p; miRNA; Proliferation

Indexed keywords

MICRORNA; MICRORNA 125A 3P; PAXILLIN; PROTEIN KINASE B; PROTEIN KINASE FYN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEK293; CELL VIABILITY; EMBRYO; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN TARGETING;

FYN; MIGRATION; MIR-125A-3P; MIRNA; PROLIFERATION;

CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PAXILLIN; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FYN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84880695313     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.123414     Document Type: Article

References (67)

1. Arai, R., Tsuda, M., Watanabe, T., Ose, T., Obuse, C., Maenaka, K., Minami, A. and Ohba, Y. (2012). Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo. Eur. J. Cancer 48, 2417-2430.
2. Ban, K., Gao, Y., Amin, H. M., Howard, A., Miller, C., Lin, Q., Leng, X., Munsell, M., Bar-Eli, M., Arlinghaus, R. B. et al. (2008). BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. Blood 111, 2904-2908.
3. Beggs, H. E., Soriano, P. and Maness, P. F. (1994). NCAM-dependent neurite outgrowth is inhibited in neurons from Fyn-minus mice. J. Cell Biol. 127, 825-833.
4. Bilal, E., Alexe, G., Yao, M., Cong, L., Kulkarni, A., Ginjala, V., Toppmeyer, D., Ganesan, S. and Bhanot, G. (2010). Identification of the YES1 kinase as a therapeutic target in basal-like breast cancers. Genes Cancer 1, 1063-1073.
5. Chen, Z. Y., Cai, L., Bie, P., Wang, S. G., Jiang, Y., Dong, J. H. and Li, X. W. (2010). Roles of Fyn in pancreatic cancer metastasis. J. Gastroenterol. Hepatol. 25,293-301.
6. Chin, J., Palop, J. J., Puolivali, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E. and Mucke, L. (2005). Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 25, 9694-9703.
7. Chitwood, D. H. and Timmermans, M. C. (2010). Small RNAs are on the move. Nature 467, 415-419.
8. Cowden Dahl, K. D., Dahl, R., Kruichak, J. N. and Hudson, L. G. (2009). The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 11 , 1208-1215.
9. Deakin, N. O. and Turner, C. E. (2008). Paxillin comes of age. J. Cell Sci. 121, 2435-2444.
10. Dey, N., Crosswell, H. E., De, P., Parsons, R., Peng, Q., Su, J. D. and Durden, D. L. (2008). The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res. 68, 1862-1871.
11. Edwards, J. (2010). Src kinase inhibitors: an emerging therapeutic treatment option forprostate cancer. Expert Opin. Investig. Drugs 19, 605-614.
12. Gallo, A., Tandon, M., Alevizos, I. and Illei, G. G. (2012). The majority ofmicroRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7,e30679.
13. Gambari, R., Fabbri, E., Borgatti, M., Lampronti, I., Finotti, A., Brognara, E., Bianchi, N., Manicardi, A., Marchelli, R. and Corradini, R. (2011). Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem. Pharmacol. 82, 1416-1429.
14. Garcia, S., Dales, J. P., Charafe-Jauffret, E., Carpentier-Meunier, S., Andrac-Meyer, L., Jacquemier, J., Andonian, C., Lavaut, M. N., Allasia, C., Bonnier, P. et al. (2007). Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. Int. J. Oncol. 31, 49-58.
15. Guo, X., Wu, Y. and Hartley, R. S. (2009). MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 6, 575-583.
16. Hardwick, J. S. and Sefton, B. M. (1995). Activation ofthe Lcktyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc. Natl. Acad. Sci. USA 92, 4527-4531.
17. He, Z., Tang, F., Ermakova, S., Li, M., Zhao, Q., Cho, Y. Y., Ma, W. Y., Choi, H. S., Bode, A. M., Yang, C. S. et al. (2008). Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Mol. Carcinog. 47, 172-183.
18. Hitosugi, T., Sato, M., Sasaki, K. and Umezawa, Y. (2007). Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression ofbreast cancer cells. Cancer Res. 67, 8139-8148.
19. Huang, J., Asawa, T., Takato, T. and Sakai, R. (2003). Cooperative roles of Fyn and cortactin in cell migration ofmetastatic murine melanoma. J. Biol. Chem. 278, 48367-48376.
20. Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P. and Clark, E. (2007). Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection.Cancer Res. 67, 2226-2238.
21. Inui, M., Martello, G. and Piccolo, S. (2010). MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11, 264-275.
22. Jiang, L., Huang, Q., Zhang, S., Zhang, Q., Chang, J., Qiu, X. and Wang, E. (2010). Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 10, 318.
23. John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C. and Marks, D. S. (2004). Human MicroRNA targets. PLoS Biol. 2, e363.
24. Kefalas, P., Brown, T. R. and Brickell, P. M. (1995). Signalling by the p60c-src family of protein-tyrosine kinases. Int. J. Biochem. Cell Biol. 27, 551-563.
25. Kiezun, A., Artzi, S., Modai, S., Volk, N., Isakov, O. and Shomron, N. (2012). miRviewer: a multispecies microRNA homologous viewer. BMC Res. Notes 5, 92.
26. Kim, L. C., Song, L. and Haura, E. B. (2009). Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 6, 587-595.
27. Kim, A. N., Jeon, W. K., Lim, K. H., Lee, H. Y., Kim, W. J. and Kim, B. C. (2011).Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells. Biochem. Biophys. Res. Commun. 407,181-184.
28. Kim, J. K., Noh, J. H., Jung, K. H., Eun, J. W., Bae, H. J., Kim, M. G., Chang, Y. G., Shen, Q., Park, W. S., Lee, J. Y. et al. (2012). SIRT7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors mir-125a-5p and mir-125b. Hepatology 57, 1055-1067.
29. Kojima, N., Wang, J., Mansuy, I. M., Grant, S. G., Mayford, M. and Kandel, E. R. (1997). Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc. Natl. Acad. Sci. USA 94, 4761-4765.
30. Krek, A., Griin, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M. et al. (2005). Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500.
31. Laneve, P., Di Marcotullio, L., Gioia, U., Fiori, M. E., Ferretti, E., Gulino, A., Bozzoni, I. and Caffarelli, E. (2007). The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA 104, 7957-7962.
32. Lehembre, F., Yilmaz, M., Wicki, A., Schomber, T., Strittmatter, K., Ziegler, D., Kren, A., Went, P., Derksen, P. W., Berns, A. et al. (2008). NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J. 27, 2603-2615.
33. Levi, M., Maro, B. and Shalgi, R. (2010). Fyn kinase is involved in cleavage furrow ingression during meiosis and mitosis. Reproduction 140, 827-834.
34. Levi, M., Maro, B. and Shalgi, R. (2011). The conformation and activation of Fyn kinase in the oocyte determine its localisation to the spindle poles and cleavage furrow. Reprod. Fertil. Dev. 23, 846-857.
35. Lewin, B., Siu, A., Baker, C., Dang, D., Schnitt, R., Eisapooran, P. and Ramos, D. M. (2010). Expression of Fyn kinase modulates EMT in oral cancer cells. Anticancer Res. 30, 2591-2596.
36. Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
37. Llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M. and Yamamoto, T. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
38. Majid, S., Saini, S., Dar, A. A., Hirata, H., Shahryari, V., Tanaka, Y., Yamamura, S., Ueno, K., Zaman, M. S., Singh, K. et al. (2011). MicroRNA-205 inhibits Src- mediated oncogenic pathways in renal cancer. Cancer Res. 71, 2611-2621.
39. Martín-Cófreces, N. B., Sancho, D., Fernández, E., Vicente-Manzanares, M., Gordón-Alonso, M., Montoya, M. C., Michel, F., Acuto, O., Alarcon, B. and Sánchez-Madrid, F. (2006). Role of Fyn in the rearrangement of tubulin cytoskeleton induced through TCR. J. Immunol. 176, 4201-4207.
40. Menten, P., Saccani, A., Dillen, C., Wuyts, A., Struyf, S., Proost, P., Mantovani, A., Wang, J. M. and Van Damme, J. (2002). Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma. J. Leukoc. Biol. 72, 780-789.
41. Miyakawa, T., Yagi, T., Taniguchi, M., Matsuura, H., Tateishi, K. and Niki, H. (1995). Enhanced susceptibility of audiogenic seizures in Fyn-kinase deficient mice. Brain Res. Mol. Brain Res. 28, 349-352.
42. Miyamoto, Y., Yamauchi, J. and Tanoue, A. (2008). Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J. Neurosci. 28, 8326-8337.
43. Nakayama, Y., Matsui, Y., Takeda, Y., Okamoto, M., Abe, K., Fukumoto, Y. and Yamaguchi, N. (2012). c-Src but not Fyn promotes proper spindle orientation in early prometaphase. J. Biol. Chem. 287, 24905-24915.
44. Nussbaum, T., Samarin, J., Ehemann, V., Bissinger, M., Ryschich, E., Khamidjanov, A., Yu, X., Gretz, N., Schirmacher, P. and Breuhahn, K. (2008). Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. Hepatology 48, 146-156.
45. O'Day, E. and Lal, A. (2010). MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 12, 201.
46. Oneyama, C., Iino, T., Saito, K., Suzuki, K., Ogawa, A. and Okada, M. (2009). Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain. Mol. Cell Biol. 29, 6462-6472.
47. Parsons, S. J. and Parsons, J. T. (2004). Src family kinases, key regulators of signal transduction. Oncogene 23, 7906-7909.
48. Posadas, E. M., Al-Ahmadie, H., Robinson, V. L., Jagadeeswaran, R., Otto, K., Kasza, K. E., Tretiakov, M., Siddiqui, J., Pienta, K. J., Stadler, W. M. et al. (2009). FYN is overexpressed in human prostate cancer. BJU Int. 103, 171-177.
49. Prag, S., Lepekhin, E. A., Kolkova, K., Hartmann-Petersen, R., Kawa, A., Walmod, P. S., Belman, V., Gallagher, H. C., Berezin, V., Bock, E. et al. (2002). NCAM regulates cell motility. J. Cell Sci. 115, 283-292.
50. Rivera, J. and Olivera, A. (2007). Src family kinases and lipid mediators in control of allergic inflammation. Immunol. Rev. 217, 255-268.
51. Roche, S. (1998). [Tyrosine kinases of the Src family, enzymes with multiple functions: from the growth of fibroblasts to the migration of epithelial cells]. C. R. Seances Soc. Biol. Fil. 192, 357-365.
52. Saito, Y. D., Jensen, A. R., Salgia, R. and Posadas, E. M. (2010). Fyn: a novel molecular target in cancer. Cancer 116, 1629-1637.
53. Schmid, R. S., Graff, R. D., Schaller, M. D., Chen, S., Schachner, M., Hemperly, J. J. and Maness, P. F. (1999). NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells. J. Neurobiol. 38, 542-558.
54. Scott, G. K., Goga, A., Bhaumik, D., Berger, C. E., Sullivan, C. S. and Benz, C. C. (2007). Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 282, 1479-1486.
55. Talmor-Cohen, A., Tomashov-Matar, R., Tsai, W. B., Kinsey, W. H. and Shalgi, R. (2004). Fyn kinase-tubulin interaction during meiosis of rat eggs. Reproduction 128, 387-393.
56. Tang, X., Feng, Y. and Ye, K. (2007). Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-activating Akt, preventing its apoptotic cleavage and promoting cell survival. Cell Death Differ. 14, 368-377.
57. Testa, J. R. and Tsichlis, P. N. (2005). AKT signaling in normal and malignant cells.Oncogene 24, 7391-7393.
58. Teutschbein, J., Schartl, M. and Meierjohann, S. (2009). Interaction of Xiphophorus and murine Fyn with focal adhesion kinase. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 149, 168-174.
59. Thomas, S. M. and Brugge, J. S. (1997). Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13, 513-609.
60. Umemori, H., Sato, S., Yagi, T., Aizawa, S. and Yamamoto, T. (1994). Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 367, 572-576.
61. Volberg, T., Romer, L., Zamir, E. and Geiger, B. (2001). pp60(c-src) and related tyrosine kinases: a role in the assembly and reorganization ofmatrix adhesions. J. Cell .Sci. 114, 2279-2289.
62. Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J., Stoop, H., Nagel, R., Liu, Y. P., van Duijse, J., Drost, J., Griekspoor, A. et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169-1181.
63. Wang, H., Leavitt, L., Ramaswamy, R. and Rapraeger, A. C. (2010). Interaction of syndecan and alpha6beta4 integrin cytoplasmic domains: regulation of ErbB2-mediated integrin activation. J. Biol. Chem. 285, 13569-13579.
64. Wu, L. and Belasco, J. G. (2005). Micro-RNA regulation ofthe mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 25,9198-9208.
65. Yadav, V. and Denning, M. F. (2011). Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol. Carcinog. 50, 346-352.
66. Zhang, Y., Gao, J. S., Tang, X., Tucker, L. D., Quesenberry, P., Rigoutsos, I. and Ramratnam, B. (2009). MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett. 583, 3725-3730.
67. Zhao, G., Chen, J., Deng, Y., Gao, F., Zhu, J., Feng, Z., Lv, X. and Zhao, Z. (2011). Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells. Biochem. Biophys. Res. Commun. 408, 154-159.